Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Option Care Health (OPCH) Cash from Financing Activities (2016 - 2025)

Option Care Health (OPCH) has disclosed Cash from Financing Activities for 17 consecutive years, with -$99.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Financing Activities fell 4.26% year-over-year to -$99.4 million, compared with a TTM value of -$277.3 million through Dec 2025, down 27.08%, and an annual FY2025 reading of -$277.3 million, down 27.08% over the prior year.
  • Cash from Financing Activities was -$99.4 million for Q4 2025 at Option Care Health, down from -$16.7 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $18.8 million in Q2 2022 and bottomed at -$107.3 million in Q1 2025.
  • Average Cash from Financing Activities over 5 years is -$41.1 million, with a median of -$36.5 million recorded in 2024.
  • The sharpest move saw Cash from Financing Activities soared 735.49% in 2022, then plummeted 8064.17% in 2023.
  • Year by year, Cash from Financing Activities stood at -$65.8 million in 2021, then skyrocketed by 98.31% to -$1.1 million in 2022, then crashed by 6905.22% to -$77.8 million in 2023, then decreased by 22.55% to -$95.4 million in 2024, then decreased by 4.26% to -$99.4 million in 2025.
  • Business Quant data shows Cash from Financing Activities for OPCH at -$99.4 million in Q4 2025, -$16.7 million in Q3 2025, and -$53.9 million in Q2 2025.